OTC grows 4% at Pfizer thanks to Nexium

4 February 2016 - Deborah Wilkes

Archived

Worldwide sales by Pfizer's Consumer Healthcare business increased by 4% on an operational basis in the fourth quarter of 2015 "primarily due to Nexium 24HR in the US".

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: